Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OP2000 in active ulcerative colitis
NCT00033943Phase 3Completed
- Sponsor
- Incara Pharmaceuticals Corporation
- Start
- Jan 2001
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deligoparin in ulcerative colitis (UC), sponsored by Incara Pharmaceuticals Corporation. Started Jan 2001; status: completed.
02
Drugs
deligoparin
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00033943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033943.